Filing metadata

Accession number
0001209191-23-031298
Form type
Form 4
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
May 22, 2023
Reporting period
May 18, 2023
Description
Insider transaction

Explore SEC Filings Hub